Forty-four breast carcinomas were studied for loss of heterozygosity (LOH) at 25 microsatellite markers distributed almost evenly along chromosome arm 22q. LOH at at least one marker were observed in 66% tumors, while 6 regions of consistent LOH were identified. The size of each region ranged betwee
Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers
β Scribed by Ikuo Yana; Hiroki Kurahashi; Shoji Nakamori; Masao Kameyama; Tsutomu Nakamura; Motohisa Takami; Takesada Mori; Shinichiro Takai; Isamu Nishisho
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 552 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
To date, several tumor-suppressor genes responsible for the tumorigenesis of colorectal cancer have been identified. However, studies of loss of heterozygosity (LOH) have suggested several chromosomal regions which may contain additional tumor-suppressor genes for colorectal cancer. To determine the extent and variation of allelic loss on 22q. on which LOH has been frequently observed, a total of 68 sporadic colorectal cancers was examined for LOH on the chromosome arm by means of 16 polymorphic DNA markers. LOH was observed in 28 tumors (4 lo/), of which 9 showed LOH at all informative loci. The remaining 19 tumors showed variable patterns of partial loss on 22q. delimiting the smallest region of overlap (SRO) between D22S90 and D22S94. Moreover, LOH within the SRO correlated with a progression in terms of Dukes' stages. These results suggest that an additional tumor-suppressor gene for colorectal cancer may exist on 22q distally to the NF2 locus and that inactivation of the gene may possibly play a role in the progression or metastasis of colorectal cancers.
π SIMILAR VOLUMES
Loss of heterozygosity (LOH) was examined at 27 loci on chromosomes 3p, 6q, I Ip, 13q. 17 and X in 42 human ovarian tumors. LOH was detected in I 2 of 26 (46%) and 5 of I 2 (42%) informative cases at 2 chromosome 13q loci, D13S32 and D I3534 respectively. On chromosome Xp, tumor-specific allele loss
Loss of heterozygosity (LOH) at loci from chromosome I3 is frequently observed in breast cancer. Chromosome I3 contains at least two cancer genes, the well-characterized RBI gene located at 13q 14 and the breast cancer-susceptibility gene, BRCAZ, recently localized to 13q 12. To investigate the poss
## Forty -six cases of sporadic melanoma have been investigated for loss of heterozygosity at 4 loci: D I IS29 ( I lq23), YNZ22 (I 7p I 3.3), 7P53 (I 7p I 3. I ); and NM23 ( 17q22). Each of the loci is thought to be important in the pathogenesis of other turnours. Mutations were found infrequently
Four genetic poljmorphisms in the AP C and MCC genes at chromosome 5q21 were analysed for loss of heterozygosity &OH) in 97 primary squamous carcinomas and adenocarcinomas of the lung. LOH was identified in at least two polymorphic loci in 41 percent of informative cases. There was no significant di
## Abstract Loss of heterozygosity (LOH) at chromosome 3p21 is frequent in cervical cancers. The candidate tumor suppressor gene, __RASSF1A__ located at 3p21.3, is found to be inactivated in several major human cancers, implicating its significance in carcinogenesis. We aimed to investigate the sta